Illustration of a discectomy surgery at the L4-S1 vertebrae. For the first time in the United States, titanium bone-anchored implants were used to repair large annular defects during diskectomies. For ...
BOSTON, Sept. 2, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical technology company committed to redefining the standard of care for lumbar discectomy patients with large annular defects ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Published results showed a decrease in the use of ...
Annular closure devices substantially reduce the risk of needing a reoperation. To reduce the risks of reherniation and reoperation, physicians can consider the use of devices that are implanted into ...
The MarketWatch News Department was not involved in the creation of this content. BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid(R) Annular Closure ...
BOSTON, June 19, 2025 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company committed to redefining the standard of care for lumbar discectomy patients with large annular defects by ...
Discectomy is a common outpatient spinal procedure, but for patients with large annular defects (>5mm), outcomes can be unpredictable and sometimes devastating. In a session at Becker’s 22nd Spine, ...
BOSTON, April 10, 2025 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company driving to change the standard of care for lumbar discectomy patients with large annular defects by reducing ...
NEW YORK, June 12, 2019 /PRNewswire/ -- NYU Langone Health last month became the first center in the United States to perform a discectomy with repair of a large annular defect using a titanium ...
OctaSeal offers a unique combination of intradiscal, anatomic placement and tubular-based insertion, avoiding the need for bone removal, defect widening, or additional nerve retraction. The implant ...
BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid® Annular Closure Device, announced today that the American Medical Association (AMA) has published a new ...